Salt intake in mineralocorticoid receptor antagonist-treated primary aldosteronism: foe or ally?

Stelios Fountoulakis; Labrini Papanastasiou; Nikolaos Voulgaris; Theodora Kounadi; Αthina Markou; George Chrousos; George Piaditis

doi:10.1007/s42000-019-00167-9

Related publications

Editorial Material2024

Mineralocorticoid receptor antagonist for chronic kidney disease, risk or benefit?

Bi Huang, Garry McDowell, Anirudh Rao, Professor Gregory Lip

Article2020

Figure 2: [Renin-Independent Aldosteronism or Primary Aldosteronism...].

Nektaria Papadopoulou‐Marketou, Anand Vaidya, Robert Dluhy, George Chrousos

Article2017

Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure

Francesco Clemenza, Serge Masson, Pier Giulio Conaldi, Daniele Di Carlo, Alessandro Boccanelli, Gian Francesco Mureddu, Lucio Gonzini, Donata Lucci, Aldo Maggioni, Andrea Di Lenarda, Enrico Nicolis, Massimo Vanasia, Roberto Latini

Article1980

Lateralization procedures in primary aldosteronism

H. Vetter, G. Brecht, Manfred M. Fischer, M. Galanski, K. Gl�nzer, Benedikt Cramer, G Pouliadis, G Sialer, A. Studer, W. Tenschert, Sabine Wollnik, H Zumkley, W. Vetter

Klinische Wochenschrift

Chapter in a book1983

Localization of te Adrenal Lesions in Primary Aldosteronism

Manfred M. Fischer, W. Vetter, M. Galanski, B Winterberg, H. Vetter